Our finding that low plasma adiponectin levels are not associated with ARDS is in contrast to results from models of LPS-induced lung injury in obesity-prone mice, where exogenous adiponectin upregulated vascular barrier-enhancing molecules and attenuated lung injury [38]. This evidence concerns the gene ADIPOQ and obesity disorder.